The Predictors for Continuous Renal Replacement Therapy in Liver Transplant Patient

February 26, 2013 updated by: Yonsei University

Background. Acute renal failure after liver transplantation (LT) requiring continuous renal replacement therapy (CRRT) adversely affects patient survival. However, there are few reports to assess the predictors for postoperative CRRT in liver transplant patients. The investigators undertook this study to identify perioperative factors that would predict patients at risk of CRRT.

Patients and Methods. The investigators retrospectively reviewed the data of 148 liver transplant patients from January 2007 to November 2010 at Severance Hospital, Yonsei University HealthSystem, in Seoul, Korea. The number of patients treated with CRRT was 44 (18 patients from living and 26 from deceased donors) and those without CRRT was 104. Univariate and stepwise logistic multivariate analyses were performed.

Study Overview

Status

Completed

Study Type

Observational

Enrollment (Actual)

148

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

19 years to 65 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

the data of 148 liver transplant patients from January 2008 to December 2011 at Severance Hospital, Yonsei University HealthSystem, in Seoul, Korea. The number of patients treated with CRRT was 44 (18 patients from living and 26 from deceased donors) and those without CRRT was 104.

Description

Inclusion Criteria:

  • Age 19-65 year
  • Liver transplant patients from January 2008 to December 2011

Exclusion Criteria:

  • Patients treated with CRRT before transplantation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
liver transplantation

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
status before operation
Time Frame: 1 day before operation
laboratory data(ex : total bilirubin, albumin, coagulation factors, blood gas analysis(arterial CO2 pressure. Blood urea nitrate/Creatinine, Hemoglobin/Hematocrit.)
1 day before operation
the amount of ascites
Time Frame: intraoperative
intraoperative
the duration of anesthesia and operation
Time Frame: intraoperative
intraoperative
intraoperative hemodynamic instability
Time Frame: intraoperative
intraoperative
intraoperative bleeding
Time Frame: intraoperative
intraoperative
Intraoperative urine output
Time Frame: intraoperative
intraoperative
the types of donation(living or deceased donor)
Time Frame: intraoperative
intraoperative
survival rate
Time Frame: on the postoperative 28th days, 365 days
on the postoperative 28th days, 365 days
postoperative bleeding amount
Time Frame: on the postoperative 28th days, 365 days.
on the postoperative 28th days, 365 days.
postoperative CRRT(continuous renal replacement therapy),
Time Frame: on the postoperative 28th days, 365days
on the postoperative 28th days, 365days
mortality
Time Frame: on the postoperative 28th days, 365 days.
on the postoperative 28th days, 365 days.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2011

Primary Completion (ACTUAL)

February 1, 2011

Study Completion (ACTUAL)

February 1, 2011

Study Registration Dates

First Submitted

October 4, 2011

First Submitted That Met QC Criteria

October 21, 2011

First Posted (ESTIMATE)

October 24, 2011

Study Record Updates

Last Update Posted (ESTIMATE)

February 27, 2013

Last Update Submitted That Met QC Criteria

February 26, 2013

Last Verified

February 1, 2013

More Information

Terms related to this study

Other Study ID Numbers

  • 4-2010-0671

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Liver Transplantation

Subscribe